A novel image cytometric method for quantitation of immunohistochemical staining of cytoplasmic antigens

M Guillaud1, J B Matthews, A Harrison

  • 1Cancer Imaging Department, BC Cancer Research Centre, Vancouver, Canada.

Insights

A new VORSTAIN software method uses Voronoi tessellation to quantify molecular marker staining intensity in tissues. This automated image cytometry approach improves consistency and reveals tumor heterogeneity, aiding prognostication.

Area of Science:

  • Computational pathology
  • Biomedical image analysis
  • Cancer research

Background:

  • Traditional immunohistochemical evaluation relies on subjective pathologist assessment.
  • Quantitative analysis of non-nuclear staining is limited by challenges in defining cellular boundaries.
  • Automated image cytometry offers potential for objective and consistent molecular marker evaluation.

Purpose of the Study:

  • To introduce VORSTAIN software for quantitative assessment of molecular marker expression.
  • To develop a novel image histometric method for defining cellular regions and measuring staining intensity.
  • To evaluate the accuracy and reproducibility of VORSTAIN compared to traditional methods.

Main Methods:

  • Development of VORSTAIN software based on the Oncometrics CytoSavant Automated Image Cytometry System.
  • Application of Voronoi tessellation to approximate cellular boundaries using nuclear centroid positions.
  • Quantitative measurement of staining intensity within defined cellular regions in human breast cancer tissue sections.

Main Results:

  • VORSTAIN demonstrated low intra-observer (1.5-2.6%) and inter-observer (1.8-4.4%) variation.
  • Quantitative staining density analysis correlated well with subjective pathologist scoring.
  • The software detected significant intratumoral heterogeneity in molecular marker expression.

Conclusions:

  • VORSTAIN provides a reliable and consistent method for quantitative immunohistochemical analysis.
  • The software accurately quantifies molecular marker expression and reveals tumor heterogeneity.
  • Accurate measurement of tumor heterogeneity using VORSTAIN may enhance cancer prognostication.